Construction of recombinant fowlpox virus(rFpv) expressing HIV-1 Gag-pol protein

被引:2
作者
Teng Hong-gang [1 ]
Lu Shuai-ran [1 ]
Liu Da-wei [1 ]
Jiang Chun-lai [1 ]
Zhang Xi-zhen [1 ]
Yu Xiang-hui [1 ]
Kong Wei [1 ]
机构
[1] Jilin Univ, Coll Life Sci, Vaccine Res Ctr, Changchun 130012, Peoples R China
基金
中国国家自然科学基金;
关键词
HIV; Gag-pol; recombinant fowlpox virus; rFPV;
D O I
10.1016/S1005-9040(07)60013-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The induction of human immunodeficiency virus(HIV)-specific T-cell response is generally considered as critical to the development of effective immunity to HIV type 1 (HIV-1). Recombinant Avipoxvirus vectors are used widely for vaccination against HIV-1, where the induction of a cytotoxic CD8+ T-cell(CTL) response seems to be an important component of protective immunity. A recombinant fowlpox virus(rFPV/Gag-pol) expressing the Gag-pol protein of HIV was constructed and characterized. The specific expression protein in CEF cells infected by recombinant fowlpox and the specific antibody in the sera of mice immunized with rFPV were analyzed via Western-blot.
引用
收藏
页码:64 / 68
页数:5
相关论文
共 21 条
[1]   Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen [J].
Allen, TM ;
Vogel, TU ;
Fuller, DH ;
Mothé, BR ;
Steffen, S ;
Boyson, JE ;
Shipley, T ;
Fuller, J ;
Hanke, T ;
Sette, A ;
Altman, JD ;
Moss, B ;
McMichael, AJ ;
Watkins, DI .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4968-4978
[2]   Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines [J].
Amara, RR ;
Villinger, F ;
Staprans, SI ;
Altman, JD ;
Montefiori, DC ;
Kozyr, NL ;
Xu, Y ;
Wyatt, LS ;
Earl, PL ;
Herndon, JG ;
McClure, HM ;
Moss, B ;
Robinson, HL .
JOURNAL OF VIROLOGY, 2002, 76 (15) :7625-7631
[3]   Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus [J].
Anderson, RJ ;
Hannan, CM ;
Gilbert, SC ;
Laidlaw, SM ;
Sheu, EG ;
Korten, S ;
Sinden, R ;
Butcher, GA ;
Skinner, MA ;
Hill, AVS .
JOURNAL OF IMMUNOLOGY, 2004, 172 (05) :3094-3100
[4]   POTENTIAL USE OF NONREPLICATING VECTORS AS RECOMBINANT VACCINES [J].
BAXBY, D ;
PAOLETTI, E .
VACCINE, 1992, 10 (01) :8-9
[5]   Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide [J].
Blomquist, DV ;
Green, P ;
Laidlaw, SM ;
Skinner, MA ;
Borrow, P ;
Duarte, CA .
VIRAL IMMUNOLOGY, 2002, 15 (02) :337-356
[6]  
Goulder PJR, 1999, AIDS, V13, pS121
[7]  
Grosenbach DW, 2001, CANCER RES, V61, P4497
[8]  
Hodge JW, 2003, CANCER RES, V63, P7942
[9]   Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors [J].
Irvine, KR ;
Chamberlain, RS ;
Shulman, EP ;
Surman, DR ;
Rosenberg, SA ;
Restifo, NP .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (21) :1595-1601
[10]  
Jiang CL, 2005, CHEM RES CHINESE U, V21, P287